Authors: Griffin, AD Perry, AS Fleming, DM

Citation: Ad. Griffin et al., Cost-effectiveness analysis of inhaled zanamivir in the treatment of influenza A and B in high-risk patients, PHARMACOECO, 19(3), 2001, pp. 293-301

Authors: Mauskopf, JA Cates, SC Griffin, AD Neighbors, DM Lamb, SC Rutherford, C

Citation: Ja. Mauskopf et al., Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in Australia, PHARMACOECO, 17(6), 2000, pp. 611-620

Authors: Aoki, FY Fleming, DM Griffin, AD Lacey, LA Edmundson, S

Citation: Fy. Aoki et al., Impact of zanamivir treatment on productivity, health status and healthcare resource use in patients with influenza, PHARMACOECO, 17(2), 2000, pp. 187-195

Authors: Herzig, KA Falk, MC Jonsson, JR Axelsen, RA Griffin, AD Hawley, CM Rigby, RJ Cobcroft, R Nicol, DL Powell, EE Johnson, DW

Citation: Ka. Herzig et al., Novel surveillance and cure of a donor-transmitted lymphoma in a renal allograft recipient, TRANSPLANT, 70(1), 2000, pp. 149-152

Authors: Mauskopf, JA Cates, SC Griffin, AD

Citation: Ja. Mauskopf et al., A pharmacoeconomic model for the treatment of influenza, PHARMACOECO, 16, 1999, pp. 73-84

Authors: Jonsson, JR Gill, D Hogan, PG Clouston, AD Edwards-Smith, C Griffin, AD Balderson, GA Lynch, SV Strong, RW Powell, EE

Citation: Jr. Jonsson et al., Role of donor leukocyte chimerism in establishing the etiology of neutropenia after liver transplantation, TRANSPLANT, 67(10), 1999, pp. 1358-1361